Literature DB >> 30190834

Familial risk of melanoma and links with other cancers.

Kachiu C Lee1,1, H William Higgins2,2, Abrar A Qureshi2,2.   

Abstract

The genetic risk factors for melanoma are complex and involve both familial and environmental components. Of the thousands of melanomas diagnosed each year, only a fraction are due to familial causes. These melanomas typically present in younger individuals, and may be associated with genetic factors that put these individuals at risk for other tumors. CDKN2A and CDK4 are the most well-characterized mutations, as they have been identified in up to 40% of familial melanomas. Individuals with CDKN2A are also at risk for pancreatic cancer. The BRCA2 mutation has also been implicated in familial melanomas, breast and ovarian cancer. The BAP1, TERC and POT1 mutations are associated with melanomas and several other familial tumors.

Entities:  

Keywords:  BAP1; BRCA2; CDK4; CDKN2A; POT1; TERC; genetics; melanoma

Year:  2015        PMID: 30190834      PMCID: PMC6094698          DOI: 10.2217/mmt.14.34

Source DB:  PubMed          Journal:  Melanoma Manag        ISSN: 2045-0885


  57 in total

1.  Genetic epidemiology of melanoma: of consortia and conundrums.

Authors:  Gloria M Petersen; Celine M Vachon
Journal:  J Natl Cancer Inst       Date:  2002-06-19       Impact factor: 13.506

Review 2.  Driver mutations in melanoma: lessons learned from bench-to-bedside studies.

Authors:  Janice M Mehnert; Harriet M Kluger
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

3.  Telomeres and chromosomal instability in chronic lymphocytic leukemia.

Authors:  L Véronèse; O Tournilhac; M Callanan; N Prie; F Kwiatkowski; P Combes; M Chauvet; F Davi; L Gouas; P Verrelle; R Guièze; P Vago; J O Bay; A Tchirkov
Journal:  Leukemia       Date:  2012-07-13       Impact factor: 11.528

4.  Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.

Authors:  Mohamed H Abdel-Rahman; Robert Pilarski; Colleen M Cebulla; James B Massengill; Benjamin N Christopher; Getachew Boru; Peter Hovland; Frederick H Davidorf
Journal:  J Med Genet       Date:  2011-09-22       Impact factor: 6.318

5.  Frequent mutation of BAP1 in metastasizing uveal melanomas.

Authors:  J William Harbour; Michael D Onken; Elisha D O Roberson; Shenghui Duan; Li Cao; Lori A Worley; M Laurin Council; Katie A Matatall; Cynthia Helms; Anne M Bowcock
Journal:  Science       Date:  2010-11-04       Impact factor: 47.728

6.  Cancer risks in BRCA2 mutation carriers.

Authors: 
Journal:  J Natl Cancer Inst       Date:  1999-08-04       Impact factor: 13.506

7.  Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study.

Authors:  Fergal J Moloney; Pascale Guitera; Elliot Coates; Nikolas K Haass; Kenneth Ho; Ritta Khoury; Rachel L O'Connell; Leo Raudonikis; Helen Schmid; Graham J Mann; Scott W Menzies
Journal:  JAMA Dermatol       Date:  2014-08       Impact factor: 10.282

Review 8.  The genetics of melanoma: recent advances.

Authors:  Victoria K Hill; Jared J Gartner; Yardena Samuels; Alisa M Goldstein
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-07-12       Impact factor: 8.929

Review 9.  Primary malignant melanoma of the vulva--an aggressive tumor for modeling the genesis of non-UV light-associated melanomas.

Authors:  Boel K Ragnarsson-Olding
Journal:  Acta Oncol       Date:  2004       Impact factor: 4.089

10.  High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.

Authors:  Hildur Helgadottir; Veronica Höiom; Göran Jönsson; Rainer Tuominen; Christian Ingvar; Ake Borg; Håkan Olsson; Johan Hansson
Journal:  J Med Genet       Date:  2014-06-16       Impact factor: 6.318

View more
  2 in total

1.  LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21/E-cadherin axis.

Authors:  Liangcai Wu; Lifei Zhu; Yanchang Li; Zhixin Zheng; Xi Lin; Chaoying Yang
Journal:  Cancer Cell Int       Date:  2020-01-10       Impact factor: 5.722

2.  Study on Early Onset Melanoma and Germ-Line Mutation in CDKN2A among Patients in Imam Khomeini Hospital Complex.

Authors:  Samira Ferdosi; Mojtaba Saffari; Razieh Alishahi; Alireza Ghanadan; Reza Shirkohi
Journal:  Asian Pac J Cancer Prev       Date:  2021-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.